All posts by: Michael Zand

About Michael Zand

DOH approves first gov’t hospital for stem cell services – Sun.Star

Continue reading

2016-01-28

DOH approves first gov’t hospital for stem cell services
Sun.Star
THE state-run Lung Center of the Philippines (LCP) on Thursday became the first government health facility to be accredited to provide stem cell services in the country. In an advisory, the Department of Health (DOH) added one more facility among those …

Continue reading

2016-01-28

Proactive Investors Australia

Cynata Therapeutics gains green light for stem cell clinical trial
Proactive Investors Australia
Cynata Therapeutics (ASX:CYP) has received favourable advice from the UK Medicines and Healthcare products Regulatory Agency for its Cymerus™ mesenchymal stem cell product to be used in clinical trials in patients with graft versus host disease.
Cynata Receives Favourable Advice from UK Regulatory Authorityirasia.com (press release)
Cynata to trial CymerusThe Australian (blog)

all 6 news articles »

Continue reading

2016-01-28

Autologous Stem Cell and Non-stem Cell Based Therapies Market Propelled by Growing Scope of Use in Cosmetic
Medgadget.com (blog)
Transparency Market Research has created a new report on the pharmaceutical industry. The research report, titled “Autologous Stem Cell and Non-Stem Cell Based Therapies Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast …
Combating the threat of stem cell tourism through patient education and government regulationDove Medical Press

all 2 news articles »

Continue reading

2016-01-28

Boost for stem cell research
The Hindu
Flush with a large grant, researchers from four institutes in the country will undertake an ambitious international project to use stem cells to study and treat disorders of the brain and blood. Called ‘Accelerating the application of Stem Cell

Continue reading

2016-01-27

Tech Times

Stem Cell Work Advances Toward Device That Would Shield Insulin-Producing Cells From Attack
AJMC.com Managed Markets Network
Collaborative work involving scientists at Massachusetts Institute of Technology and Harvard’s Stem Cell Institute has produced a device designed to overcome one of the challenges of replacing insulin-producing beta cells—helping them survive attack
Shielded cells treat diabetesNature.com
Buh-bye Insulin Injections? Encapsulated Pancreatic Cells Could Cure Diabetes For Up To Six MonthsTech Times
Encapsulated human islet cells can normalize blood sugar levels in mice(e) Science News (press release) (registration)
U.S. News & World Report
all 24 news articles »